SETD3 and breast carcinoma: In line with this result, a group of studies found that SETD3 are correlated with HCC (13, 20), breast cancer (17), colon cancer (14), B-cell lymphoma (21), cervical cancer (16), renal cell tumors (22), and ovarian carcinoma (23), suggestive of a potential biomarker for prognosis of different cancers.